Detailed answers about UK KAAISI CARE EYES PRODUCT LIMITED, including incorporation, status, business activity, and accounts information.
When was UK KAAISI CARE EYES PRODUCT LIMITED founded?
UK KAAISI CARE EYES PRODUCT LIMITED was officially incorporated on 27 February 2024 and is registered under company number 15527038. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is UK KAAISI CARE EYES PRODUCT LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of UK KAAISI CARE EYES PRODUCT LIMITED?
UK KAAISI CARE EYES PRODUCT LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does UK KAAISI CARE EYES PRODUCT LIMITED do?
UK KAAISI CARE EYES PRODUCT LIMITED operates in the following sectors: 47782 - Retail sale by opticians, 64204 - Activities of distribution holding companies, 64304 - Activities of open-ended investment companies, 86101 - Hospital activities. These SIC codes provide insight into the company's business activities and industry focus.
What is UK KAAISI CARE EYES PRODUCT LIMITED's registered address?
The registered office address of UK KAAISI CARE EYES PRODUCT LIMITED is OFFICE SUITE 29A, 3/F,, 23 WHARF STREET, LONDON, ENGLAND, SE8 3GG. This is the official address filed with Companies House for legal and statutory correspondence.
Is UK KAAISI CARE EYES PRODUCT LIMITED financially stable?
The most recent accounts for UK KAAISI CARE EYES PRODUCT LIMITED were made up to 28 February 2025, filed as DORMANT. Next accounts are due by 30 November 2026.